HIV-1 virion fusion assay: uncoating not required and no effect of Nef on fusion

被引:55
作者
Cavrois, M
Neidleman, J
Yonemoto, W
Fenard, D
Greene, WC
机构
[1] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA 94141 USA
[3] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94141 USA
关键词
HIV-1; fusion; infectivity; virions; Nef; primary cells; uncoating;
D O I
10.1016/j.virol.2004.07.015
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We recently described a sensitive and specific assay that detects the fusion of HIV-1 virions to a broad range of target cells, including primary CD4 cells. This assay involves the use of virions containing beta-lactamase-Vpr (BlaM-Vpr) and the loading of target cells with CCF2, a fluorogenic substrate of beta-lactamase. Since Vpr strongly associates with the viral core, uncoating of the viral particle might be required for effective cleavage of CCF2 by BlaM-Vpr. Here, we show that BlaM-Vpr within mature viral cores effectively cleaves CCF2, indicating that this assay measures virion fusion independently of uncoating. We also show that wildtype and Nef-deficient HIV-1 virions fuse with equivalent efficiency to HeLa-CD4 cells, SupT1 T cells, and primary CD4 T cells. Since Nef enhances cytoplasmic delivery of viral cores and increases viral infectivity, these findings indicate that Nef enhances an early post-fusion event in the multistep process of viral entry. Possible sites of Nef action include enlargement of the fusion pore, enhanced uncoating of viral particles, and more efficient passage of viral cores through the dense cortical actin network located immediately beneath the plasma membrane. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:36 / 44
页数:9
相关论文
共 43 条
[11]   Human immunodeficiency virus type 1 particles pseudotyped with envelope proteins that fuse at low pH no longer require Nef for optimal infectivity [J].
Chazal, N ;
Singer, G ;
Aiken, C ;
Hammarskjöld, ML ;
Rekosh, D .
JOURNAL OF VIROLOGY, 2001, 75 (08) :4014-4018
[12]   THE GROWTH ADVANTAGE CONFERRED BY HIV-1 NEF IS DETERMINED AT THE LEVEL OF VIRAL-DNA FORMATION AND IS INDEPENDENT OF CD4 DOWN-REGULATION [J].
CHOWERS, MY ;
PANDORI, MW ;
SPINA, CA ;
RICHMAN, DD ;
GUATELLI, JC .
VIROLOGY, 1995, 212 (02) :451-457
[13]   The membrane-proximal tyrosine-based sorting signal of human immunodeficiency virus type 1 gp41 is required for optimal viral infectivity [J].
Day, JR ;
Münk, C ;
Guatelli, JC .
JOURNAL OF VIROLOGY, 2004, 78 (03) :1069-1079
[14]   Disassembly of human immunodeficiency virus type 1 cores in vitro reveals association of Nef with the subviral ribonucleoprotein complex [J].
Forshey, BM ;
Aiken, C .
JOURNAL OF VIROLOGY, 2003, 77 (07) :4409-4414
[15]   SPECIFIC INCORPORATION OF CYCLOPHILIN-A INTO HIV-1 VIRIONS [J].
FRANKE, EK ;
YUAN, HEH ;
LUBAN, J .
NATURE, 1994, 372 (6504) :359-362
[16]   GENERATION OF HUMAN MONOCLONAL-ANTIBODIES TO HUMAN IMMUNODEFICIENCY VIRUS [J].
GORNY, MK ;
GIANAKAKOS, V ;
SHARPE, S ;
ZOLLAPAZNER, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (05) :1624-1628
[17]   Charting HIV's remarkable voyage through the cell: Basic science as a passport to future therapy [J].
Greene, WC ;
Peterlin, BM .
NATURE MEDICINE, 2002, 8 (07) :673-680
[18]   Characterization of HIV-1 Vpr nuclear import: Analysis of signals and pathways [J].
Jenkins, Y ;
McEntee, M ;
Weis, K ;
Greene, WC .
JOURNAL OF CELL BIOLOGY, 1998, 143 (04) :875-885
[19]   Restoration of wild-type infectivity to human immunodeficiency virus type 1 strains lacking nef by intravirion reverse transcription [J].
Khan, M ;
Garcia-Barrio, M ;
Powell, MD .
JOURNAL OF VIROLOGY, 2001, 75 (24) :12081-12087
[20]   Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner [J].
Lama, J ;
Mangasarian, A ;
Trono, D .
CURRENT BIOLOGY, 1999, 9 (12) :622-631